Physician profile
Kartic Rajput
NPI 1306006705
$2,500.84
in general payments reported to CMS, 2019-2025
25 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $66.79 · 2021: $466 · 2022: $378 · 2023: $611 · 2024: $217 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $500.69 | 2019-2024 | Senza |
| Spr Therapeutics, INC | $477.91 | 2021-2024 | Sprint Pns System |
| Medtronic, INC. | $358.94 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $239.23 | 2019-2023 | Proclaim |
| Grt US Holding, INC. | $167.00 | 2022 | |
| Relievant Medsystems, INC. | $157.72 | 2023 | Intracept |
| Stimwave Technologies Incorporated | $108.79 | 2019 | |
| Vertos Medical, INC. | $82.73 | 2023-2024 | Mild Device Kit |
| Stryker Corporation | $45.89 | 2022-2023 | Spinejack |
| Medtronic USA, INC. | $40.21 | 2019 | |
| Si-Bone, INC. | $36.98 | 2024 | |
| Biotronik Nro, INC. | $32.14 | 2025 | Prospera |
| Otsuka America Pharmaceutical, INC. | $30.76 | 2019 | |
| Boston Scientific Corporation | $28.75 | 2021 | |
| Abbvie INC. | $25.13 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $23.72 | 2025 | Wegovy |
| Alkermes, INC. | $21.03 | 2021 | |
| Allergan, INC. | $20.23 | 2021 | |
| Globus Medical, INC. | $19.60 | 2025 | Senza |
| Ironshore Pharmaceuticals INC. | $18.82 | 2019 | |
| Neurocrine Biosciences, INC. | $16.21 | 2019 | |
| Curonix LLC | $14.40 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Janssen Pharmaceuticals, INC | $11.75 | 2019 | |
| Sunovion Pharmaceuticals INC. | $11.40 | 2019 | |
| Shire North American Group INC | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kartic Rajput listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.